secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0001104659-24-090522
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics announces 1-for-25 reverse stock split effective Aug 26, 2024
-------------------------------------------------------------------------------

- Reverse split at 1-for-25 ratio; outstanding shares reduce from ~25.1M to ~1.0M.
- Effective 12:01 a.m. ET on Aug 26, 2024; trading on split-adjusted basis same day.
- Split intended to meet NYSE American per-share price listing requirements.
- No fractional shares issued; holders of fractional shares get rounded up to next whole share.
- CUSIP changes to 87164U 508; ticker remains TOVX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465924090522/0001104659-24-090522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465924090522/tm2421949d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-090522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer